The 20 Best Cholangiocarcinoma (Bile Duct Cancer) Doctors Near Me in Wexford, PA

. Dr. Kaiser is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Emphysema, Lung Nodules, Visceromegaly, and Gallbladder Disease.

. Dr. Blodgett is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Visceromegaly, Diverticular Disease, and Emphysema.

. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Ascites, Bile Duct Stricture, Alcoholic Cirrhosis, Gastrostomy, and Bone Marrow Aspiration.

Jennifer Chennat, MD, specializes in pancreatobiliary diseases and is board-certified in gastroenterology by the American Board of Internal Medicine. She practices at UPMC Digestive Health Care and is affiliated with UPMC Horizon, UPMC St. Margaret, UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC Shadyside, UPMC Presbyterian, and UPMC Mercy. Dr. Chennat received her medical degree from Thomas Jefferson University Sidney Kimmel Medical College. She completed her residency at Thomas Jefferson University Hospital and fellowships at Loyola University Medical Center and the University of Chicago Medical Center. Dr. Chennat is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Hereditary Pancreatitis, Acute Pancreatitis, Chronic Pancreatitis, Endoscopy, and Pancreatectomy.

Samer Tohme is a General Surgeon in Pittsburgh, Pennsylvania. Dr. Tohme has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Hepatic Ischemia, Liver Cancer, Fibrolamellar Carcinoma, Hepatectomy, and Liver Transplant. Dr. Tohme is currently accepting new patients.

Melanie C. Ongchin, MD, FACS, is a surgical oncologist and specializes in the treatment of recurrent malignancies and peritoneal carcinomatosis.Dr. Ongchin is board-certified in general surgery and complex surgical oncology. She received her medical degree from the University of Medicine and Dentistry of New Jersey, New Jersey Medical School in Newark, N.J. Dr. Ongchin completed a research fellowship at Roswell Park Cancer Institute in Buffalo, N.Y. She also completed a residency at the State University of New York, University at Buffalo in N.Y., followed by a fellowship in surgical oncology at UPMC.Dr. Ongchin is a member of the Society of Surgical Oncology and the American College of Surgeons. Dr. Ongchin is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Pseudomyxoma Peritonei, Melanoma, Colorectal Cancer, Hernia Surgery, and Small Bowel Resection.

Adam Slivka, MD, PhD, is a Professor at the University of Pittsburgh School of Medicine and the Associate Chief of Clinical Affairs for the Division of Gastroenterology, Hepatology, and Nutrition at the University of Pittsburgh School of Medicine. Dr. Slivka is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Hereditary Pancreatitis, Chronic Pancreatitis, Acute Pancreatitis, Endoscopy, and Pancreaticoduodenectomy.

William Nelson is a General Surgeon in Wexford, Pennsylvania. Dr. Nelson is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Cholecystitis, Gallbladder Disease, Hernia, and Hernia Surgery.

Gursimran Kochhar is a Gastroenterologist in Wexford, Pennsylvania. Dr. Kochhar is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Viral Gastroenteritis, Hemorrhagic Proctocolitis, Ulcerative Colitis, Endoscopy, and Colonoscopy.

Paul Lee, MD, specializes in diagnostic radiology and vascular interventional radiology and is board-certified in interventional radiology and diagnostic radiology by the American Board of Radiology. He is affiliated wiht UPMC Horizon, UPMC Shadyside, UPMC Mercy, UPMC Presbyterian, UPMC St. Margaret, UPMC Passavant, UPMC East, UPMC Northwest, UPMC McKeesport, UPMC Bedford, UMPC Altoona, UPMC Magee-Womens Hospital and UPMC Hamot. Dr. Lee received his medical degree from the University of Illinois College of Medicine and completed his residency and fellowship at the University of Pittsburgh School of Medicine. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Retroperitoneal Fibrosis, Intussusception in Children, Ascites, Liver Embolization, and Pacemaker Implantation.

John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.

Anwaar Saeed, MD, is an Associate Professor of Medicine and the Chief of the Gastrointestinal (GI) Medical Oncology Program at the University of Pittsburgh, University of Pittsburgh Medical Center (UPMC), and UPMC Hillman Cancer Center. She also serves as the Vice Chair of the Colorectal Cancer Committee of the NSABP Foundation. Her research efforts are focused on immune modulatory approaches in patients with gastric & esophageal cancer, colon cancer and hepatocellular carcinoma as well as chemoprevention/ immunoprevention in the high-risk GI population. She has published more than 150 peer reviewed papers, posters and book chapters, and have led more than 40 clinical trials, focused on various immune modulatory regimens including but not limited to immune checkpoint inhibitor combinations with chemotherapy, other checkpoint inhibitors, antibody drug conjugates, bi-specific T cell engagers (BiTE), angiogenesis inhibitors, as well as immunotherapy combinations with regional approaches like stereotactic radiosurgery and intensity-modulated radiation therapy. She currently leads several investigator-initiated trials focused on novel targeted immunotherapy combinations including the ongoing phase I/II CAMILLA multicohort study looking at Cabozantinib plus Durvalumab with or without Tremelimumab in GI malignancies. Results from phase I/II part of the CAMILLA led to the development of the currently ongoing global pivotal trial, STELLAR 303, in patients with previously treated microsatellite stable colorectal cancer. She is also the study chair for a soon to open SWOG/intergroup NCI national trial (S2303) testing a novel chemo-immunotherapy regimen in patients with advanced gastric & esophageal adenocarcinoma. Dr. Saeed is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Stomach Cancer, Familial Colorectal Cancer, and Gamma Knife Radiosurgery.

James F. Pingpank Jr., MD, is an associate professor of surgery at the University of Pittsburgh School of Medicine. Dr. Pingpank specializes in regional treatment strategies for advance malignancies of the liver and peritoneal cavity. Dr. Pingpank is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Neuroendocrine Tumor, Liver Embolization, and Hernia Surgery.

Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular.Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Abhinav Humar, MD, is the clinical director of the Thomas E. Starzl Transplantation Institute and chief of UPMC Transplant Services. He received his medical degree from the University of Ottawa where he also completed his general surgical residency. He completed his surgical fellowship in transplantation at the University of Minnesota. Dr. Humar is a member of the American Society of Transplant Surgeons and the International Liver Transplantation Society with more than 600 abstracts accepted at national and international transplant meetings and has co-authored more than 200 manuscripts, 30 book chapters and two books.Dr. Humar’s clinical interests include living donor and split liver transplants and studies of hepatic regeneration.View Dr. Humar’s full list of publications from PubMed. Dr. Humar is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Liver Failure, Fibrolamellar Carcinoma, Liver Cancer, Liver Transplant, and Kidney Transplant.

Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC.Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as an Advanced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Endoscopy, and Gamma Knife Radiosurgery.

Ashim K. Dayalan, MD, specializes and is certified in internal medicine by the American Board of Internal Medicine. He practices at GMA/Dayalan and Associates, Family Medicine and is affiliated with UPMC Passavant. Dr. Dayalan completed his residency at St Francis Medical Center and medical degree at Bangalore Medical College & Research Institute. Dr. Dayalan is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Vitamin B12 Deficiency Anemia, Folate Deficiency, Multiple Carboxylase Deficiency, Hip Replacement, and Pacemaker Implantation.

Charles Gabbert, MD, specializes in gastroenterology and is certified in internal medicine and gastroenterology by the American Board of Internal Medicine. He practices at University of Pittsburgh Physicians, Department of Medicine, Division of Gastroenterology, and is affiliated with UPMC Mercy, UPMC Magee-Womens Hospital, UPMC St Margaret, UPMC Presbyterian, and UPMC Shadyside. He completed his medical degree at Oregon Health and Science University. Dr. Gabbert is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Bile Duct Obstruction, Bile Duct Stricture, Cholestasis, Endoscopy, and Colonoscopy.

John Lech, DO, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in the treatment of gastrointestinal malignancies and peritoneal carcinomas. Dr. Lech is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.

Hongmei Liang, MD, PhD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center at UPMC St. Margaret. Board certified in internal medicine and medical oncology, Dr. Liang received her medical degree from Shandong Medical University, Jinan in Shandong, China and PhD in immunology at the University of Pittsburgh School of Medicine. She completed her residency in internal medicine at Greater Baltimore Medical Center in Maryland and fellowship in hematology and oncology at the University of Pittsburgh Medical Center. Dr. Liang is rated as an Experienced provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Pleuropulmonary Blastoma.